|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.070 USD | -3.27% |
|
-5.48% | -74.22% |
| 05-07 | Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Lipocine Inc Spyros Papapetropoulos resigns as board member effective April 16, 2026 | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- LPCN Stock
- Consensus Lipocine Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
